Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
Abstract | PURPOSE: MATERIALS AND METHODS: We retrospectively analyzed clinical and pathological characteristics, and long-term outcomes in 110 patients uniformly treated with primary chemotherapy between 1994 and 2016. The primary objective was to evaluate long-term disease-free survival. We also explored factors associated with the need for additional treatment. RESULTS: CONCLUSIONS:
|
Authors | J Aparicio, A Sánchez-Muñoz, S Ochenduszko, J Gumà, A Fernández-Aramburo, X García Del Muro, V Quiroga, J Sastre, T Alonso-Gordoa, N Sagastibelza, P Maroto, A Gómez de Liaño, S Vázquez, P Diz, I Durán, M Domenech, A Pinto, A Hernández, E González-Billalabeitia, J Terrasa |
Journal | The Journal of urology
(J Urol)
Vol. 202
Issue 4
Pg. 742-747
(10 2019)
ISSN: 1527-3792 [Electronic] United States |
PMID | 31163007
(Publication Type: Journal Article)
|
Chemical References |
- Chorionic Gonadotropin, beta Subunit, Human
- alpha-Fetoproteins
|
Topics |
- Adult
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Carcinoma, Embryonal
(blood, drug therapy, mortality)
- Chemotherapy, Adjuvant
(methods)
- Chorionic Gonadotropin, beta Subunit, Human
(blood)
- Disease-Free Survival
- Follow-Up Studies
- Humans
- Male
- Neoplasm Recurrence, Local
(epidemiology, prevention & control)
- Neoplasms, Germ Cell and Embryonal
(blood, mortality, therapy)
- Orchiectomy
- Testicular Neoplasms
(blood, mortality, therapy)
- Testis
(diagnostic imaging, pathology)
- Young Adult
- alpha-Fetoproteins
(analysis)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|